The historical rank and industry rank for Austar Lifesciences's OCF Margin % or its related term are showing as below:
AULSF'
s OCF Margin % Range Over the Past 10 Years
Min: -9.5 Med: -1.45 Max: 8.63
Current: 8.65
During the past 13 years, the highest OCF Margin % of Austar Lifesciences was 8.63%. The lowest was -9.50%. And the median was -1.45%.
AULSF's OCF Margin % is ranked better than 54.85% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: 5.86
vs AULSF: 8.65
Austar Lifesciences OCF Margin % Related Terms
Austar Lifesciences OCF Margin % Historical Data
* Premium members only.
The historical data trend for Austar Lifesciences's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Austar Lifesciences's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Austar Lifesciences OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Austar Lifesciences's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Austar Lifesciences's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Austar Lifesciences (AULSF) has a OCF Margin % of 10.72% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Austar Lifesciences and its competitors. According to the industry distribution chart, Austar Lifesciences ranks #368 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 45.2%.
Is Austar Lifesciences' OCF Margin % too high?
Austar Lifesciences' current OCF Margin % is 10.72%. The Medical Devices & Instruments industry median OCF Margin % is 5.86. Austar Lifesciences' value of 10.72% is 82.9% above this industry median. Based on the distribution chart, Austar Lifesciences ranks #368 out of 815 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Austar Lifesciences has a GF Score™ of 49/100, reflecting its overall financial health beyond just this single metric.
How does Austar Lifesciences' OCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Austar Lifesciences ranks #368 out of 815 companies for OCF Margin %. This puts Austar Lifesciences in the upper half of its industry. The industry median OCF Margin % is 5.86. Austar Lifesciences' value of 10.72% is 82.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.86, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Austar Lifesciences's current OCF Margin % of 10.72% is 82.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Austar Lifesciences and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Austar Lifesciences's current OCF Margin % is 10.72%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Austar Lifesciences stock overvalued right now?
Austar Lifesciences (AULSF) has a current OCF Margin % of 10.72%. The stock's GF Value™ is $0.10, compared to a current price of $0.07 — trading 30% below its estimated fair value. The current OCF Margin % is 10.72% and 82.9% above the Medical Devices & Instruments industry median of 5.86. Austar Lifesciences' overall GF Score™ is 49/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Austar Lifesciences (AULSF), the current OCF Margin % is 10.72% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Austar Lifesciences (AULSF) Overvalued in 2026?
Based on GuruFocus' analysis, Austar Lifesciences stock appears to be undervalued.
The current stock price of $0.07 is trading 30% below its estimated GF Value™ of $0.10.
Key valuation signals for AULSF:
OCF Margin %: 10.72%
GF Value™: $0.10 vs. price of $0.07 (30% below fair value)
Industry Position: 82.9% above the Medical Devices & Instruments median (#368 of 815)
No single metric tells the full story. See the AULSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Austar Lifesciences Ltd is an investment holding company, and its subsidiaries are principally engaged in providing integrated engineering solutions to pharmaceutical manufacturers and research institutes, as well as manufacturing and distribution of pharmaceutical equipment and consumables in the PRC. Its products include Clean Utility Equipment & Chemical Pharmaceutical Preparation System and others. It has three business segment groups: Integrated Process and Packaging Equipment & Systems (IPS), which generates maximum revenue and combines the original business segments of Liquid and Bioprocess System and Powder and Solid System; Consulting, Digitalization, and Construction; and Life Science Equipment and Consumables. The Group generates maximum revenue from Mainland China.
49GF Score
Get the complete analysis for AULSF
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AULSF has been successfully added to your 
